Full approval would allow Pfizer and BioNTech to market the vaccine directly to customers. If the FDA grants full approval, it could also help raise confidence in the vaccine. The agency is also expected to issue an emergency authorisation for use of the Pfizer-BioNTech vaccine in 12- to 15-year-olds next week. The companies have said that they plan to file for emergency authorisation for 2- to 11-year-olds in September. Moderna plans to apply for full approval for its COVID-19 vaccine this month, the company said during its quarterly earnings call Thursday.

Source: bd News24 May 07, 2021 15:56 UTC